Skip to main content

. 1970 Aug 15;3(5719):388. doi: 10.1136/bmj.3.5719.388

Monoamine oxidase inhibitors and L-dopa.

K R Hunter, A J Boakes, D R Laurence, G M Stern

PMCID: PMC1701271 PMID: 5451592

388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

DEGKWITZ R., FROWEIN R., KULENKAMPFF C., MOHS U. [On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6]. Klin Wochenschr. 1960 Feb 1;38:120–123. doi: 10.1007/BF02189076. [DOI] [PubMed] [Google Scholar]
Elis J., Laurence D. R., Mattie H., Prichard B. N. Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure. Br Med J. 1967 Apr 8;2(5544):75–78. doi: 10.1136/bmj.2.5544.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
Goodall M., Alton H. Dopamine (3-hydroxytyramine) metabolism in parkinsonism. J Clin Invest. 1969 Dec;48(12):2300–2308. doi: 10.1172/JCI106196. [DOI] [PMC free article] [PubMed] [Google Scholar]
HODGE J. V., NYE E. R., EMERSON G. W. MONOAMINE-OXIDASE INHIBITORS, BROAD BEANS, AND HYPERTENSION. Lancet. 1964 May 16;1(7342):1108–1108. doi: 10.1016/s0140-6736(64)91316-9. [DOI] [PubMed] [Google Scholar]
HORWITZ D., FOX SM 3. D., GOLDBERG L. I. Effects of Dopamine in man. Circ Res. 1962 Feb;10:237–243. doi: 10.1161/01.res.10.2.237. [DOI] [PubMed] [Google Scholar]
Simmons A. V., Carr D., Ross E. J. Case of self-poisoning with multiple antidepressant drugs. Lancet. 1970 Jan 31;1(7640):214–215. doi: 10.1016/s0140-6736(70)90573-8. [DOI] [PubMed] [Google Scholar]
Sjöqvist F. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances. Proc R Soc Med. 1965 Nov;58(11 Pt 2):967–978. [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES